Articles published by Syros Pharmaceuticals, Inc.

Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration

February 28, 2025

From Syros Pharmaceuticals, Inc.

Via Business Wire

Tickers SYRS

Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome

January 26, 2023

From Syros Pharmaceuticals, Inc.

Via Business Wire

Tickers SYRS

Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement

September 16, 2022

From Syros Pharmaceuticals, Inc.

Via Business Wire

Tickers SYRS

Syros and Tyme Technologies Announce Stockholder Approval of Merger

September 15, 2022

From Syros Pharmaceuticals, Inc.

Via Business Wire

Tickers SYRS TYME

Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment of Pancreatic Cancer

September 13, 2022

From Syros Pharmaceuticals, Inc.

Via Business Wire

Tickers SYRS

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions